Companies Dominating the Gabapentin Market
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Ascend Laboratories
- LLC Apotex Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma.
- Amneal Pharmaceuticals LLC.
- Cipla USA, Inc.
- BP Pharmaceuticals Laboratories Company
- Assertio Holdings, Inc.
- Arbor Pharmaceuticals, Inc.
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Gabapentin Market in 2025 is assessed at USD 2.31 billion.
The global market size was worth around USD 2.22 billion in 2024 and is set to register a CAGR of over 5%, exceeding USD 4.19 billion revenue by 2037.
North America is on pace to surpass USD 1.47 billion by 2037, driven by growing prevalence of chronic pain conditions and high demand for gabapentin in the United States and Canada.
The major players in the market include Sun Pharmaceutical Industries Ltd., Ascend Laboratories, LLC Apotex Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma., Amneal Pharmaceuticals LLC., Cipla USA, Inc., BP Pharmaceuticals Laboratories Company, Assertio Holdings, Inc., Arbor Pharmaceuticals, Inc., Pfizer Inc.
